Document is current
Any future updates will be listed below
-
Authors
Pour, Mohammad
James, Linda
Singh, Kamlendra https://orcid.org/0000-0001-6153-8929
Mampunza, Samuel
Baer, Franklin
Scott, JoAnna
Berg, Michael G.
Rodgers, Mary A.
Cloherty, Gavin A.
Hackett Jr, John
McArthur, Carole P.
-
Funding
Funding for this research was provided by:
Office of Research, Graduate Studies and Economic Development, University of Missouri
- License Information
-
More Information
Article History
Received: 1 March 2020
Accepted: 23 October 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: Ethics approval and consent to participate was obtained from Université Protestante au Congo (UPC) institutional review board. Participants (primarily adults) received a rapid HIV test at one of 35 hospitals or clinics in 2017 during the pilot phase, and 47 similar sites (12 additional) in 2018. Patients were tested by HIV serology without cost to them and confirmed following the National algorithm (Determine HIV-1/2 [Determine; Alere, USA], Uni-Gold HIV [Uni-Gold; Trinity Biotech, Ireland], and Vikia HIV 1/2 [Vikia; bioMérieux, France]).
: Consent for publication was obtained as part of the consent process and approved by Université Protestante au Congo (UPC).
: JHJr, GAC, MGB, and MAR are employees and shareholders of Abbott Laboratories.
